bempedoic acid/ezetimibe vs ezetimibe
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of bempedoic acid/ezetimibe and ezetimibe. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Table 4 lists drug interactions with NEXLIZET that have been identified in studies with bempedoic acid or ezetimibe. Cyclosporine Clinical Impact: Concomitant use of NEXLIZET and cyclosporine increases ezetimibe and cyclosporine concentrations. The degree of increase in ezetimibe exposure may be greater in patients with severe renal insufficiency [see Clinical Pharmacology (12.3) ] .
Nexlizet
Zetia
Nexlizet is a combination medicine that helps lower cholesterol. It is used with diet and exercise to lower LDL-C (bad cholesterol) in adults.
No summary available.
Nexlizet is used to lower LDL-C (bad cholesterol) in adults who have high cholesterol. This includes people with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). One of the medicines in Nexlizet can also lower the risk of heart problems like heart attack and stroke in adults who are at high risk and cannot take statins.
Information not available.
Nexlizet contains two medicines that work in different ways to lower cholesterol. Bempedoic acid blocks an enzyme in your liver that makes cholesterol. Ezetimibe stops your body from absorbing cholesterol from food.
Information not available.
- • Upper respiratory tract infection (like a cold)
- • Muscle spasms
- • High uric acid levels in the blood
- • Back pain
- • Stomach pain or discomfort
- • Headache
- • Upper respiratory tract infection
- • Muscle pain
- • Diarrhea
- Muscle pain 53
- Joint pain 51
- Pain in your arms or legs 40
- Muscle spasms 32
- Tiredness 30
- Fatigue 4,663
- Nausea 4,195
- Myalgia 4,191
- Diarrhoea 3,662
- Dizziness 3,338
This medicine can raise uric acid levels in your blood, which can cause gout. Tell your doctor if you have symptoms of high uric acid, like joint pain or swelling. Nexlizet can also increase your risk of tendon rupture. Stop taking Nexlizet and call your doctor right away if you have tendon pain, swelling, or difficulty moving.
No specific warnings noted.
This medicine may harm your unborn baby. Do not take Nexlizet if you are pregnant or planning to become pregnant. Talk to your doctor about other ways to lower your cholesterol during pregnancy.
No pregnancy information available.
How to Read This bempedoic acid/ezetimibe vs ezetimibe Comparison
bempedoic acid/ezetimibe is classified in the ACL Inhibitor / Cholesterol Absorption Inhibitor drug class, while ezetimibe sits within the Cholesterol Absorption Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, bempedoic acid/ezetimibe has 206 submissions while ezetimibe has 20,049. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these medicines increase each other's levels in the body, and this effect can be even stronger if you have severe kidney issues.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for bempedoic acid/ezetimibe or ezetimibe.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.